Amrize Ltd
AMRZ · NYSE
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | $27 | $27 | $29 | $29 |
| - Cash | $1 | $1 | $0 | $2 |
| + Debt | $7 | $7 | $6 | $6 |
| Enterprise Value | $33 | $34 | $35 | $33 |
| Revenue | $4 | $3 | $2 | $3 |
| % Growth | 14.1% | 54.7% | -27% | – |
| Gross Profit | $1 | $1 | $0 | $1 |
| % Margin | 29.6% | 30% | 10.7% | 27.3% |
| EBITDA | $1 | $1 | $0 | $1 |
| % Margin | 27.6% | 27.7% | 9.5% | 24.4% |
| Net Income | $1 | $0 | -$0 | $0 |
| % Margin | 14.8% | 13.3% | -2.6% | 16.1% |
| EPS Diluted | 0.99 | 0.78 | -0.1 | 0.83 |
| % Growth | 26.9% | 883.9% | -112% | – |
| Operating Cash Flow | $1 | $0 | -$1 | $2 |
| Capital Expenditures | -$0 | -$0 | -$0 | -$0 |
| Free Cash Flow | $1 | $0 | -$1 | $2 |